Ropes & Gray Attorneys Author Article on EMA’s Draft Policy Re: Clinical-Trial Data

Time to Read: 1 minutes Practices: Health Care

Boston health care partner Mark Barnes, Washington, D.C. life sciences counsel Kellie Combs and Boston corporate associate David Peloquin co-authored an article entitled “EMA Draft Policy on Publication and Access to Clinical Trials Data Provides Broad Researcher Access to Participant-Level Data” with Harvard Medical School professor Barbara Bierer. In the article—published on July 17 in Bloomberg BNA’s Medical Research Law & Policy Report  and is scheduled to republish in Bloomberg BNA’s Life Sciences Law & Industry Report in August—the authors discuss unanswered questions raised by the European Medicines Agency’s (EMA) draft policy and the impact the EMA’s final policy will have once it takes effect, likely on January 1, 2014. 
Click here to read the article.
Cookie Settings